Article
Cell Biology
San Xu, Zhuan Zhou, Xingzhi Peng, Xuxiu Tao, Peijun Zhou, Kun Zhang, Jinwu Peng, Dan Li, Liangfang Shen, Lifang Yang
Summary: Studies have shown that LMP1 enhances autophagy by upregulating BNIP3 expression, leading to increased radioresistance in nasopharyngeal carcinoma cells. Through the ERK/HIF1α signaling axis, LMP1 promotes the binding of BNIP3 to Beclin1 and competitively reduces the binding of Bcl-2 to Beclin1, thereby upregulating autophagy. Knockdown of BNIP3 reduces radioresistance mediated by protective autophagy, highlighting its crucial role in LMP1-positive nasopharyngeal carcinoma cells' protection against irradiation.
CELL DEATH & DISEASE
(2021)
Article
Pharmacology & Pharmacy
Xiao Guan, Dan Yu, Mengjie HuangFu, Zhiyi Huang, Tong Dou, Yisa Liu, Luwei Zhou, Xumei Li, Lin Wang, Haiping Liu, Juan Wang, Xu Chen
Summary: The study demonstrated that curcumol inhibits invasion and metastasis of EBV-positive NPC cells by targeting NCL, which further regulates related signaling pathways, providing a new pharmacological basis for clinical treatment.
BIOCHEMICAL PHARMACOLOGY
(2021)
Article
Microbiology
Kina Kase, Satoru Kondo, Naohiro Wakisaka, Hirotomo Dochi, Harue Mizokami, Eiji Kobayashi, Makoto Kano, Takeshi Komori, Nobuyuki Hirai, Takayoshi Ueno, Yosuke Nakanishi, Miyako Hatano, Kazuhira Endo, Makiko Moriyama-Kita, Hisashi Sugimoto, Tomokazu Yoshizaki
Summary: The study found that LMP1 can induce the expression of sPD-L1 and PD-L1 in vitro and that the expression of LMP1 is significantly correlated with PD-L1 in NPC patients. Additionally, the serum level of sPD-L1 in NPC patients was higher than in controls, particularly in advanced stage patients. However, the expression of LMP1, PD-L1, and sPD-L1 levels were not associated with prognosis.
Article
Biotechnology & Applied Microbiology
Saidu Kamara, Yanru Guo, Shanshan Mao, Xiaoxian Ye, Qingfeng Li, Maolin Zheng, Jinshun Zhu, Jing Zhang, Wangqi Du, Jun Chen, Shanli Zhu, Lifang Zhang
Summary: Novel EBV LMP1 C-terminal domain affibody molecules were selected and demonstrated high affinity and specificity for EBV LMP1 protein. In tumor-bearing nude mice, these affibody molecules rapidly accumulated at the tumor site, indicating their potential as specific molecular imaging agents for EBV-associated NPC.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
(2021)
Review
Microbiology
Ana Banko, Danijela Miljanovic, Ivana Lazarevic, Andja Cirkovic
Summary: This study investigated the connection between LMP1 gene variability and NPC development, finding an association between 30bp deletion and Xhol loss with NPC susceptibility, but 30bp deletion could not distinguish NPC from EBV-associated non-NPC tumors. Certain EBV variants were rare in NPC individuals, signaling the need for further research to verify the biological significance of these differences.
Article
Immunology
Yanru Guo, Saidu Kamara, Jing Zhang, He Wen, Maolin Zheng, Ying Liu, Luqi Zhou, Jun Chen, Shanli Zhu, Lifang Zhang
Summary: Three potential Z(LMP1-C) affibody molecules (Z(LMP1-C)15, Z(LMP1-C)114 and Z(LMP1-C)277) were found to have specific binding interactions with recombinant and native EBV LMP1, showing high antitumor effects on EBV-positive NPC cell lines without cytotoxicity towards EBV-negative NPC cell line. Among them, Z(LMP1-C)277 exhibited the highest antitumor efficacy and could decrease the phosphorylation levels of up-stream activators, leading to downstream suppression of phospho-p90RSK and c-Fos. Treatment with Z(LMP1-C)277 reduced tumor growth in mice without apparent toxicity.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
(2023)
Article
Virology
Nannan Zhu, Qian Wang, Zhidong Wu, Yan Wang, Mu-Sheng Zeng, Yan Yuan
Summary: Epstein-Barr virus (EBV) is associated with various malignant diseases, including nasopharyngeal carcinoma (NPC). The virus-encoded oncoprotein LMP1 promotes the development of cancer stem cells (CSCs) in NPC by activating the PI3K/mTOR/Akt signaling pathway. Different mTOR pathways, mTORC1 and mTORC2, contribute to the acquisition of distinct CSC characteristics and cooperate to regulate NPC metastasis.
JOURNAL OF VIROLOGY
(2022)
Article
Oncology
Tamara S. Mangiaterra, Marcela De Dios Soler, Noelia Oviedo, Sandra Colli, Maria V. Preciado, Marcela Soria, Laura Galluzo, Elena De Matteo, Paola Chabay
Summary: This study detected viral genome, as well as LMP1 and EBNA2 transcripts, in DLBCL cases from Argentina using a more sensitive method. It found that 14 cases originally considered EBV negative expressed LMP1 and/or EBNA2 transcripts. However, the viral load was lower in cases without EBERs+ cells and the expression of the oncogenic protein LMP1 was also lower, suggesting a secondary role of EBV in DLBCL pathogenesis.
INTERNATIONAL JOURNAL OF CANCER
(2023)
Article
Genetics & Heredity
Barbara G. Mueller Coan, Ethel Cesarman, Marcio Luis Acencio, Deilson Elgui de Oliveira
Summary: This study evaluated the effects of LMP1 derived from different strains of EBV on miRNA regulation in nasopharyngeal cells. The results showed that different strains of LMP1 led to differential expression of specific miRNAs, and in silico analysis provided insights into the molecular effects of LMP1 expression on cellular processes and signaling pathways.
Review
Immunology
Wenting Li, Xiaobing Duan, Xingxing Chen, Meixiao Zhan, Haichuan Peng, Ya Meng, Xiaobin Li, Xian-Yang Li, Guofu Pang, Xiaohui Dou
Summary: Epstein-Barr virus (EBV) is the first tumor virus in humans, and nasopharyngeal carcinoma (NPC) accounts for 60% of new tumor cases caused by EBV worldwide annually. Over 90% of patients with undifferentiated NPC are infected with EBV. Immunotherapy has shown significant breakthroughs in the treatment of recurrent or metastatic NPC, providing a broad prospect for NPC immunotherapy.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Multidisciplinary Sciences
Deo R. Singh, Scott E. Nelson, Abigail S. Pawelski, Alisha S. Kansra, Stuart A. Fogarty, Jillian A. Bristol, Makoto Ohashi, Eric C. Johannsen, Shannon C. Kenney
Summary: Latent Epstein-Barr virus (EBV) infection promotes undifferentiated nasopharyngeal carcinomas (NPCs) by inducing cellular proliferation and inhibiting spontaneous differentiation through the activation of YAP and TAZ. LMP1 enhances YAP and TAZ activity by reducing serine phosphorylation and increasing Src kinase-mediated phosphorylation of YAP. Knockdown of YAP and TAZ reduces proliferation and promotes differentiation in EBV-infected cells. Ibrutinib restores spontaneous differentiation and inhibits proliferation of EBV-infected cells, suggesting a potential therapeutic approach for treating NPCs.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2023)
Review
Oncology
Weixing Liu, Gui Chen, Xin Gong, Yingqi Wang, Yaoming Zheng, Xiao Liao, Wenjing Liao, Lijuan Song, Jun Xu, Xiaowen Zhang
Summary: This study found through a meta-analysis that EBV-DNA, VCA-IgA, EBNA1-IgA, and Rta-IgG detection have high accuracy in early diagnosis of nasopharyngeal carcinoma, with EBV-DNA having the highest diagnostic accuracy. Meanwhile, EA-IgA is suitable for diagnosis but not for screening of NPC.
CANCER CELL INTERNATIONAL
(2021)
Article
Biochemistry & Molecular Biology
Valerija Begic, Petra Korac, Slavko Gasparov, Marija Rozman, Petra Simicic, Snjezana Zidovec-Lepej
Summary: This study investigated the distribution of EBV genotypes 1 and 2, as well as LMP1 gene variants, in Hodgkin lymphoma patients. The results showed that EBV genotype 1 was exclusively present in all classical HL samples. Furthermore, the wild-type strain B95-8 and the Mediterranean subtype with a 30 bp deletion were found to be predominant in the distribution of EBV LMP1 variants. These findings contribute to our understanding of EBV immunobiology in cHL and have implications for the development of prophylactic and therapeutic vaccines.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Review
Otorhinolaryngology
Yue Yuan, Fei Ye, Jian-Hui Wu, Xiao-Yan Fu, Zhong-Xi Huang, Tao Zhang
Summary: This paper reviews recent advances in early screening for nasopharyngeal carcinoma (NPC) and cell-free DNA (cfDNA) methylation, highlighting the low positive predictive value (PPV) of current screening methods and the potential of combining cfDNA methylation analysis with Epstein-Barr virus (EBV) serological testing to improve PPV.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
(2023)
Article
Oncology
Satoru Kondo, Yusuke Okuno, Takayuki Murata, Hirotomo Dochi, Naohiro Wakisaka, Harue Mizokami, Makiko Moriyama-Kita, Eiji Kobayashi, Makoto Kano, Takeshi Komori, Nobuyuki Hirai, Takayoshi Ueno, Yosuke Nakanishi, Kazuhira Endo, Hisashi Sugimoto, Hiroshi Kimura, Tomokazu Yoshizaki
Summary: This study investigates the role of EBV in non-endemic nasopharyngeal carcinoma. The EBV genomes of Japanese NPC differ from those of other diseases in Japan or endemic NPC, and Japanese NPC is not affected by the endemic strain but frequently carries type 2 EBV or the strain with intermediate risk. The results highlight the importance of viral strains and viral reactivation in the pathogenesis of non-endemic NPC.